Chief Science Officer's

Washington, DC
Aug 08, 2018
Aug 13, 2018
Executive, Chief
Other, Science
Full Time
The Chief Science Officer's mandate will be leadership and enhancement of MRA's strategy to advance scientific knowledge and understanding in the prevention, diagnosis, staging and treatment of melanoma. The CSO will oversee and manage MRA's unique scientific grant-making program and process, prioritizing funding areas and award structure for promising research projects, to ensure continued development and momentum of scientific discoveries into tools and treatments for patients. Key areas of MRA interest include: developing alliances with all stakeholders, including academic, industry, non-profit and government entities, accelerating clinical and translational research in melanoma; understanding and keeping pace with the key needs of the international research agenda for melanoma; understanding and leveraging the current and anticipated melanoma pharmaceutical portfolio and pipeline; and fostering innovative strategies and solutions to address key research questions in melanoma. The CSO will guide the scientific strategy of the organization, building upon recent growth and impact in bringing better options for prevention, diagnosis and treatment to melanoma patients and those at risk. Working in partnership with the CEO, the CSO will also be the scientific face of the organization externally, charged with developing strategic relationships with academia, industry, professional organizations, policy makers and other stakeholders. About MRA - The mission of the Melanoma Research Alliance is to end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas. Annual funding for MRA research awards is approximately $8 to $10 million and, as of current, MRA has awarded over $100 million to melanoma research programs around the globe. Through our unique collaborative approach, MRA has leveraged an additional $100 million. MRA was launched in 2007 by Debra and Leon Black under the auspices of the Milken Institute, and due to the ongoing support of our founders, 100% of every donation made to MRA is able to go directly to support melanoma research. Responsibilities * Lead the MRA Science team, which includes two other staff; and work side by side with development and communications staff at MRA to advance the MRA mission. * With support provided by the Director of the Scientific Program (a direct report to the CSO), lead and facilitate Grant Review Committee, Scientific Advisory Panel and Medical Advisory Panel interactions to evaluate and capitalize upon melanoma research opportunities. This includes recruiting committee members and directing the work of the Grant Review Committee in implementing rigorous peer review, as well as ongoing oversight and prioritization of the portfolio of Team Science Awards and Individual Awards (Established Investigator, Young Investigator, Pilot/Development Awards and Partnerships). * Design and lead the implementation of MRA global research strategies and coordinate relevant global academic, government and biopharmaceutical sector research activity. * Establish, maintain and manage a comprehensive portfolio of research relationships with thought leaders in industry, academia, government, related to science and medicine to further the organization's goals, inclusive of apprising MRA and MRA stakeholders of emerging melanoma therapeutics. * Serving as ambassador to the academic research and industry communities to advance broad engagement with MRA's research program. * Promoting increased industry focus on melanoma. * Generating additional resources for MRA's mission through alliances and partnerships ensuring scientific leadership's ongoing engagement, utilization and satisfaction. * Lead MRA's engagement with key medical and clinical research organizations, including ASCO, AACR, AAD and others. * Represent MRA at highly visible national/ international scientific and clinical conferences and meetings inclusive of development of content and scientific agenda. * Represent MRA with government officials to advance the mission of MRA (including further developing key relationships within FDA and NCI/NIH). * Address field inquiries from the pharmaceutical and medical research communities on the MRA research agenda and serve as scientific spokesperson for MRA with the media. * Oversee annual Requests for Proposals, Scientific Retreat, and other core elements of the MRA scientific program. * Partner with MRA executive team, board members and key stakeholders in major gift cultivation around major gift requests. * Participate in external meetings and professional activities where relevant to focus projects and interests of MRA, including regular travel.* PhD and/or MD * 10+ years in cancer research, drug development and/or related areas of oncology (melanoma experience preferred but not required) * Experience in influencing Research & Development in melanoma and/or oncology * Publications and recognition as a key opinion leader in therapeutic area is desirable * Ability to interact and influence diverse disciplines at senior levels, including physicians and scientists, business executives, government officials and philanthropists * Excellent interpersonal, communication (written and oral), results-oriented project management, facilitation and consultative skills to influence decision making and manage key stakeholders are required * Ability to travel up to 35% of time * Successfully complete a security background check * Up to 35% travel